Bringing Together Innovators, Leading Investors and Major Healthcare Corporations
Now in its 33rd edition, MTI is Europe’s longest running healthcare investment and partnering forum, bringing together a fantastic range of breakthrough healthcare, life science and digital health firms seeking investment and partnerships with some of the most pro-active and ambitious investors in the sector.
Each event sees up to 40 technology companies pitching investment opportunities to an audience of 150 delegates including family offices, private wealth holders, VC’s, corporations, angel investors and many more. Central to the event is a forum programme that will address some of the major challenges and opportunities across healthcare, life science and digital health investment today.
Benefits of attending
The MTI events deliver the best ratio of investors to presenting companies, giving all attendees the maximum opportunity to meet, network and learn from the best in the business ensuring you meet the right investors and the right investment opportunities.
Do not miss this unique opportunity to meet with some of the most proactive entrepreneurs and investors in healthcare, learn how to fine-tune your strategy and ultimately maximise the potential for return from the sector.
The MTI forum is the place for investors, healthcare organisations and MedTech startups to meet and address the biggest topics in the industry today. With the programme agenda covering topics from advocacy and safety, and improving the patient journey, to how to identify disruptors, understanding EU regulations for MedTech, and exit strategies; it's a day that any serious MedTech investor cannot afford to miss.
Our speakers represent the truly global nature of the healthcare, life sciences and digital health sector with panellists drawn from leading investment organisations from across Europe, North America, the Middle East and Asia.
MTI is proud to once again welcome some of the industry’s most active and ambitious investors who will join us on-stage to discuss the evolution of the sector, and share the latest insight into their investment strategy. Together we will identify the most promising opportunities for MedTech investors and address upcoming challenges.
MTI is honoured to welcome back Dr Benoît Dubuis the Executive Director of Campus Biotech and the President of the world-renowned Inartis Foundation as our conference chairman for another year.
Benoît has over 30 years of international experience in Life Sciences, both in industry and in the academic world. After his engineering training, his doctorate from ETH Zurich (ETH Medal 1995) and an academic activity in Cambridge and Cranfield in England, he held various management positions in pharmaceutical companies (Chemap, Ciba-Geigy / Novartis, Lonza), before joining the École Polytechnique Fédérale de Lausanne (EPFL) where he founded the Faculty of Life Sciences.
Confirmed speakers will be updated at regular intervals as the events draws closer. If you are interested in speaking at the event please contact:
Over the last 30 events we have showcased over 1000 venture-stage healthcare, life science and digital health companies to our unrivalled audience of investors. Representing all areas of the sector our presenting companies originate from over 37 countries and are at a range of different stages from pre-clinical to commercialisation.
A selection of the previously confirmed presenting companies at MTI events include:
Why attend as a delegate?
· Be the first to uncover the latest investment opportunities from our unrivalled range of Presenting Companies
· Meet over 40 investment opportunities over the duration of just 2 days
· Network with the leading investors and world-leading healthcare corporations
· Learn how to adapt your investment strategy for today’s climate
· Take away the tools to help your portfolio companies develop and grow to their full potential
Who are the delegates?
Every year MTI brings over 150 delegates together who are working at the cutting edge of healthcare, life science and digital health investment and partnering. Our investors represent some of the most pro-active and ambitious individuals from family offices, private wealth holders, VC’s, corporate VC’s, institutional investors, angels and managed funds to name but a few.
In order to ensure the best possible mix of investors and early-stage companies admission to all MTI events is strictly controlled and open to all qualifying companies and individuals. The organisers reserve the right to restrict admittance and delegate places.
How to register
Special packages and early booking price are now available, see the Registration Page for more information or contact:
+44 (0)203 968 7453
Sponsors of the MTI events represent leading companies and organisations providing services to early to mid-stage life science companies, investors and major healthcare corporations.
Campus Biotech is a Swiss center of excellence in biotechnology and life sciences research focusing on three domains: Neuroscience & Neurotechnology, Digital Health and Global Health.
Founded in 2013 by a Consortium composed by the École polytechnique fédérale de Lausanne (EPFL), the University of Geneva (Unige), the Bertarelli Family and Hansjörg Wyss, the Campus functions like a giant incubator and focuses on pure science and its translation into real solutions and practical outcomes that have an impact on society and the world.
Campus Biotech was created to cross boundaries between disciplines and sectors, providing a unique ecosystem that brings academic, clinical, industrial and entrepreneurial actors together, to ensure projects to have access to the resources and skills that they need to push the frontiers of medical discoveries and to make breakthroughs.
Partners and scientists based at Campus Biotech become part of a diverse, dynamic culture of knowledge exchange.
For more information:
Fondation Inartis is a nonprofit whose purpose is to promote innovation, in particular in the tech and life science fields, and foster interactions between innovators, companies and research institutes.
Fondation Inartis runs different programmes such as the labs & coworking spaces UniverCité and Espace Creation, the startup accelerator MassChallenge Switzerland, the life science cluster of the Health Valley, and Inartis Network which is supported by the Swiss Confederation.
For more information, please contact:
11 Av. des Baumettes
+41 21 697 11 21
State of Vaud - Office for Economic Affairs and Innovation (SPEI)
Canton of Vaud is one of the main centers of research and innovation in Switzerland, with the largest academic and technology campus in the country and several research institutes as well as industries of international reputation, particularly in life sciences, micro-nanotechnologies, ICT and cleantech.
In a few words :
A quarter of the 100 top Swiss startups are based in Vaud including 4 of the 10 top best ones in 2018 as well as about 2,000 high-tech companies
Vaud ranked 1st in fundraising for 4 consecutive years (2014-2017) in comparison to other Swiss cantonsas Vaud-based startups have raised up to CHF 1.2 bio over the past 5 years and CHF 267.5 mio in 2018
24 scaleups are based in Vaud and created 361 new jobs in 2018
There are 7 incubators and innovation parks suitable to develop your ideas and business, pooling local infrastructure and technical skills
About CHF +32 mio financial incentives have been distributed from the State of Vaud to startups/SMEs since 2012 to support their economic development.
Through its support to the MedTech Investing Europe Conference 2022, SPEI aims to showcase our region to all the international guests for what it really is: a direct connection with world-class academic and research institutes, a dense network of internationally oriented SMEs and innovative startups, and a vibrant location offering favorable conditions to expand your business.
The Office for Economic Affairs and Innovation (SPEI) supports companies that are exclusively based in Vaud, especially those involved in the sectors of advanced technology and industry. SPEI advises entrepreneurs and puts them in contact with organizations that are appropriate to their specific needs. SPEI can also provide direct financial support.
For more information, please contact:
State of Vaud – Department of Economy, Innovation and Sport (DEIS)
Office for Economic Affairs and Innovation (SPEI)
Rue Caroline 11
CH – 1014 Lausanne
+41 21 316 58 20
BioAlps is Western Switzerland's life sciences cluster.
The Association offers a dynamic network in #medtech, #biotech and #digitalhealth. With more than 1200 companies, 63 research and academic institutions, 67 public institutions and innovation parks, 5 000 students and researchers, 35 000 jobs, the region is the number one and most diversified life sciences ecosystem in Europe. Start-up companies and large multinationals are concentrated in a small, attractive geographic area with a great infrastructure.
For more information, please contact:
Avenue de Sécheron 15
c/o Biopôle SA
Secteur Esplanade - Bâtiment Serine
Route de la Corniche 8
Wellbeing International Foundation is a medical services company that can call upon over 25 years of scientific and medical research and expertise in the fields of stem cell derived therapies and regenerative medicine.
We advise on two types of medical service: cell-free therapy based on the use of extracellular vesicle secretions, and dendritic cell treatment as an alternative, or supplement to, conventional cancer therapy.
Advantages of our treatments include no risk of tumours forming and no immunnological issues.
StrongRoom AI (“SRAI”) is a global leader in digital care management software. Our mission is to streamline clinician workflows, drug administration, facility optimization, patient adherence, and mitigate Adverse Drug Events (“ADEs”) to deliver high-strength care. Our customers include pharmacies (Strong ER), elderly care facilities (StrongCare), hospitals (StrongHospital), and other healthcare providers globally. Additionally, we have developed a suite of data security tools (StrongShield) and data analytics tools (StrongPro) which relevant to all customers.
Our enterprise solution, consisting of two generations of software — Generation I & II — is a modular platform that allows for complex customization based on administration workflows and care needs. This approach accelerates care provision while improving efficiency and significantly reducing errors for care-givers such as nurses, pharmacists, and doctors.
Generation I software streamlines drug administration workflows by introducing layers of interconnectivity and automation between care processes, practices, and external software integrations. This full-stack solution allows facilities to transition from manual administration activities or makeshift software to a robust digital infrastructure.Generation II (StrongPro) builds upon Generation I architecture to provide caregivers and clinicians AI-powered insights on patient data and analytical tools to augment drug management decision-making. This software surfaces potential risks, highlights informative care receiver information, and improves facility efficiency to enable high-strength, proactive care.
SRAI follows the highest international standards of data safety, privacy, and protection for both generations of software. The software adheres to military-grade encryption practices (AES-256) and best-in-class global cybersecurity standards (ISO27001). In terms of patient data handling, it complies with HIPAA compliance (US), GDPR (Europe), and The Privacy Act 1988 (AUS).
With operations in Australia, the UK, and US, SRAI is co-created by leading user experience experts, programmers, and practicing clinicians to ensure it is highly intuitive, simple, and user-driven.
For more information, please contact:
StrongRoom AI (“SRAI”)
Level 1, 58 Lorimer St
Contact: Peter Bruce-Clark, global president of Strong Room Technology Pty Ltd can be reach on firstname.lastname@example.org.
To enquire about sponsorship opportunities at upcoming MTI events, please contact Kevin Grant on email@example.com or Anton Paul on firstname.lastname@example.org.
Hotel Royal Savoy Lausanne
Set in the heart of Lausanne, originally built in 1909 and painstakingly restored to its pristine beauty this The Royal Savoy Hotel is now a landmark representing luxury and style complemented by an elegant yet contemporary design. Located adjacent to the majestic Lake Geneva and one hour from Geneva airport this hotel is ideal for visitors who appreciate culture, heritage and history, whilst enjoying up to date modern facilities of a first class hotel.
Please note that most of the bedrooms at the Royal Savoy are now fully booked, below some alternative hotels for your reference. If you require any assistance please contact Shadé Bull at email@example.com or +44(0)203 941 8019.
There are numerous hotels close by ranging from 3* to 5*. If you wish to stay off-site, we would suggest any of the following:
Hotel in Lausanne
Agora Swiss Night by Fassbind
Approx. CHF 274 p /night
7 min walk from venue
Alpha-Palmiers Hotel by Fassbind
Approx. CHF 269 p /night
12 min walk from venue
Approx. CHF 210 p /night
11 min walk from venue
ibis Styles Lausanne Center Mad House
Approx. CHF 207p /night
17 min walk from venue
Prices taken from April 2023. Prices may change closer to time of event.
If you have deliveries, please send your materials to:
ROYAL SAVOY HOTEL & SPA
Avenue d’Ouchy 40
1006 Lausanne – Switzerland
(Campden Wealth Event – 27 & 28 June)
Nova North, 6th Floor, 11 Bressenden Place, London, SW1E 5BY, United Kingdom